Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 32 citing Shearer: Predicted costs and outcomes from reduced vibration detection in people with diabetes.... (0.11 sec) 

The global burden of diabetic foot disease

- ptolemy.ca [PDF] 
AJM Boulton, L Vileikyte, G Ragnarson-Tennvall, J … - The Lancet, 2005 - Elsevier
Diabetic foot problems are common throughout the world, resulting in major economic consequences
for the patients, their families, and society. Foot ulcers are more likely to be of neuropathic
origin, and therefore eminently preventable, in developing countries, which will ...
Cited by 209 - Related articles - All 29 versions

The diabetic foot: from art to science. The 18th Camillo Golgi lecture

- ptolemy.ca [PDF] 
AJM Boulton - Diabetologia, 2004 - Springer
Diabetic foot ulceration represents a major medical, social and economic problem all over the
world. While more than 5% of diabetic patients have a histo- ry of foot ulceration, the cumulative
lifetime incidence may be as high as 15%. Ethnic differences exist in both ulcer and ...
Cited by 90 - Related articles - BL Direct - All 9 versions

Changing the natural history of diabetic neuropathy: incidence of ulcer/amputation …

- prsjournal.net
O Aszmann, PL Tassler, AL Dellon - Annals of plastic surgery, 2004 - journals.lww.com
From the *Department of Plastic Surgery, University of Vienna, Austria; the †Vermont Department
of Health, Burlington, Vermont; and the ‡Division of Plastic Surgery and Department of
Neurosurgery, Johns Hopkins University, Baltimore, Maryland, and Division of Plastic ...
Cited by 44 - Related articles - All 8 versions

[PDF] Consensus statement on negative pressure wound therapy (VAC® Therapy) for the …


G Andros, DG Armstrong, CE Attinger, AJM Boulton, … - Wounds, 2006 - o-wm.com
Evidence-Based Medicine Included in this manuscript is a review of current liter- ature on diabetic
foot wounds, which was examined based on the classification of evidence-based medicine as
described by The Oxford Centre for Evidence-Based Medicine.1 By classifying the ...
Cited by 32 - Related articles - View as HTML - BL Direct - All 8 versions

Reversal of diabetic peripheral neuropathy and new wound incidence: the role of …

- cooperativemedicine.com [PDF] 
MW Powell, DE Carnegie, TJ Burke - Advances in Skin & Wound Care, 2004 - journals.lww.com
Of the more than 18 million individuals in the United States who have diabetes, 15% are over
age 65.1 Health care costs in this age-group are often borne by Medicare. The direct cost of diabetes
was estimated at $78 bil- lion in 1997,2 growing to $91 billion in 2002.3 Over 51% of that ...
Cited by 27 - Related articles - BL Direct - All 16 versions

The diabetic foot


HM Rathur, AJM Boulton - Clinics in dermatology, 2007 - Elsevier
Diabetic foot problems are common throughout the world, resulting in major medical, social and
economic consequences for the patients, their families, and society. Foot ulcers are more likely
to be of neuropathic origin, and therefore eminently preventable. People at greatest risk of ...
Cited by 23 - Related articles - All 3 versions

The neuropathic diabetic foot


HM Rathur, AJM Boulton - Nature Clinical Practice Endocrinology & …, 2007 - nature.com
Haris M Rathur is a Clinical Research Fellow in the Academic Department of Medicine, University
of Manchester, Manchester, UK. Dr Rathur's research interest focuses on diabetic neuropathy
and the management of diabetic foot problems. His current research efforts include ...
Cited by 20 - Related articles - BL Direct - All 3 versions

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of …


JA Ray, WJ Valentine, S Roze, L Nicklasson, D … - Diabetes Obes …, 2007 - pt.wkhealth.com
Methods: Baseline patient characteristics and treatment effect data from the recent 'INITIATE'
clinical trial served as input to a peer-reviewed, validated Markov/Monte-Carlo simulation
model. INITIATE demonstrated improvements in HbA1c favouring BIAsp 70/30 vs. ...
Cited by 14 - Related articles - All 5 versions

Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the United …


SL Tunis, ME Minshall - Am J Manag Care, 2008 - ajmc.com
Objective: This study was designed to model the cost-effectiveness of self-monitoring of blood
glucose (SMBG) at frequencies of 1 or 3 times per day for patients with type 2 diabetes mellitus
(T2DM) who are treated with oral antidiabetic (OAD) medications within the United States.
Cited by 13 - Related articles - Cached - All 6 versions

Estimating the long-term cost-effectiveness of exenatide in the United States: an …

- pubget.com [PDF] 
ME Minshall, AK Oglesby, ME Wintle, WJ Valentine, S … - Value in Health, 2008 - pt.wkhealth.com
Methods: This analysis utilized a published and validated Markov model incorporating Monte
Carlo simulation with tracker variables to estimate the clinical and cost outcomes of adding exenatide
to a background of metformin and/or sulfonylurea treatment, with the effects of 30 years of ...
Cited by 11 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google